Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1270-1276

  Evans, David T ^a,g   O'Connor, David H ^a   Jing, Peicheng ^a   Dzuris, John L ^b   Sidney, John ^b   Da Silva, Jack ^c,h   Allen, Todd M ^a   Horton, Helen ^a   Venham, John E ^a   Rudersdorf, Richard A ^d   Vogel, Thorsten ^a   Pauza, C David ^a,e   Bontrop, Ronald E ^f   Demars, Robert ^d   Sette, Alessandro ^b   Hughes, Austin L ^c   Watkins, David I ^a,e  

^a UNIVERSITY OF WISCONSIN   (United States)

^b Epimmune   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^g HARVARD MEDICAL SCHOOL   (United States)

^h EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PEDIGREE; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS GENE; VIRUS IMMUNITY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA PRIMERS; EPITOPE MAPPING; EPITOPES; GENE PRODUCTS, ENV; GENE PRODUCTS, NEF; HISTOCOMPATIBILITY ANTIGENS CLASS I; MACACA MULATTA; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032697315     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15224     Document Type: Article

References (37)

1. Borrow, P., Lewicki, H., Hahn, B., Shaw, G. & Oldstone, M. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103-6110 (1994).
2. Koup, R. & Ho, D. Shutting down HIV. Nature 370, 416 (1994).
3. Yasutomi, Y., Reimann, K., Lord, C., Miller, M. & Letvin, N. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67, 1707-1711 (1993).
4. Reimann, K. et al. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68, 2362-2370 (1994).
5. Ogg, G.S. et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103-2106 (1998).
6. Schmitz, J.E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857-860 (1999).
7. Jin, X. et al. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991-998 (1999).
8. Matano, T. et al. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72, 164-169 (1998).
9. Couillin, I. et al. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180, 1129-34 (1994).
10. Goulder, P.J.R. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med. 3, 212-217 (1997).
11. McMichael, A.J. & Phillips, R.E. Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15, 271-296 (1997).
12. Borrow, P. et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3, 205-211 (1997).
13. Wolinsky, S.M. et al. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272, 537-542 (1996).
14. Koenig, S. et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1, 330-336 (1995).
15. Dai, L.C., West, K., Littaua, R., Takahashi, K. & Ennis, F.A. Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+A24-restricted cytotoxic T lymphocytes. J. Virol. 66, 3151 (1992).
16. Haas, G. et al. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J. Immunol. 157, 4212-4221 (1996).
17. Mortara, L. et al. Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine. J. Virol. 72, 1403-1410 (1998).
18. Price, D.A. et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94, 1890-1895 (1997).
19. Balter, M. Modest Briton stirs up storm with views on role of CTLs. Science 280, 1860-1861 (1998).
20. Brander, C. et al. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J. Clin. Invest. 101, 2559-2566 (1998).
21. Dykhuizen, M. et al. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression. J. Gen. Virol. 79, 2461-2467 (1998).
22. Pauza, C.D. et al. Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J. Med. Primatol. 22, 154-61 (1993).
23. Coffin, J.M. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489 (1995).
24. Nei, M. & Gojobori, T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Molec. Biol. Evol. 3, 418-426 (1986).
25. Hughes, A.L. & Nei, M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 335, 167-170 (1988).
26. delGuercio, M.F. et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154, 685-693 (1995).
27. Koup, R.A. et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650-4655 (1994).
28. Walker, B.D. et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345-348 (1987).
29. Koup, R.A. et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: In vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 174, 1593-1600 (1991).
30. Carmichael, A., Jin, X., Sissons, P. & Borysiewicz, L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177, 249-256 (1993).
31. Mellors, J.W. et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170 (1996).
32. McMichael, A. T cell responses and viral escape. Cell 93, 673-676 (1998).
33. Trivedi, P. et al. Selective amplification of simian immunodeficiency virus genotypes after intrarectal inoculation of rhesus monkeys. J. Virol. 62, 7649-7653 (1994).
34. van Baalen, C.A. et al. Selective in vitro expansion of HLA class I-restricted HIV-1 gag-specific CD8+ T cells: Cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 7, 781-786 (1993).
35. Voss, G. et al. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology 208, 770-775 (1995).
36. Allen, T.M. et al. Characterization of the peptide-binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from SIV. J. Immunol. 160, 6062-6071 (1998).
37. Greenwood, F., Hunter, W. & Glover, J. The preparation of 131I-labeled human growth hormone of high specific radioactivity. Biochem. J. 89, 114 (1963).